Homocysteine, Folate, Vitamin B12, and Transcobalamins in Patients Undergoing Successive Hypo- and Hyperthyroid States
Françoise Barbé,
Marc Klein,
Abalo Chango,
Sophie Frémont,
Philippe Gérard,
Georges Weryha,
Jean-Louis Guéant and
Jean-Pierre Nicolas
Departments of Biochemistry A, INSERM XR308 (F.B., A.C., S.F., P.G.,
J.-P.N.) and INSERM 0014 (P.G., J.-L.G.). and Department of
Endocrinology (M.K., G.W.), Centre Hospitalier Universitaire de Nancy,
Hôpital de BraboisHôpital dAdultes
54511 Vandoeuvre-les-Nancy, France
To the editor:
In the March 2000 issue of this journal,
Lien et al. (1) reported a transient increase
in both plasma homocysteine and serum cholesterol during short-term
iatrogenic hypothyroidism, which may confer increased
cardiovascular risk. The observations of Lien et al.
(1) are in accordance with the results of our
previous preliminary study (2).
We now repeat plasma homocysteine, serum folate, and vitamin B12
in patients with successive hypo- and hyperthyroid states.
Cobalamin-binding proteins, transcobalamins, were also determined to
explain changes in vitamin B12 concentrations. Forty-five patients
[age, 44.5 ± 12.3 yr (2378); sex ratio M/F, 11/34] who had
undergone total thyroidectomy for well-differentiated thyroid carcinoma
were studied 4 weeks after the withdrawal of thyroïdal hormone
therapy and then 14 weeks after the resumption of treatment to suppress
the thyrotropin concentration. Hypo- and thyrotoxic states were
evidenced by TSH concentrations (Table 1
). Total EDTA-plasma homocysteine, serum
folate, cobalamin, serum total B12 binding capacity, apo-haptocorrin,
and apo-transcobalamin II were measured by methods described previously
(4).
View this table:
[in this window]
[in a new window]
|
Table 1. Homocysteine, folate, vitamin B12, and
transcobalamin results in patients undergoing successive hypo- and
hyperthyroid states
|
|
Homocysteine concentrations were significantly higher in hypo-
than in hyperthyroid state (mean increase, 5.3 ± 4.6 µmol/L;
Table 1
). Furthermore, moderate hyperhomocysteinemia was observed for
10 of 45 patients (22%) with hypothyroidism [range, 17.527.2
µmol/L; reference range, 6.016.0 µmol/L (5)].
Homocysteinemia was normal in all patients in the hyperthyroid state.
On univariate analysis, homocysteine was inversely related to folate
(Rho, -0.33; P = 0.02). Our results suggested that
folate levels may account in determining homocysteine as we confirmed
the observation (1) of a moderate decline in serum folate
in hypothyroid state, with a P value at the limit of
significance (P = 0.07). Vitamin B12 was significantly
higher in the hypothyroid state than in the hyperthyroid state, as
found by Lien et al. (1). Transcobalamin levels
were determined attempting to explain changes in vitamin B12
concentrations. Except in two cases, apo-haptocorrin was low in all
patients in the two states whereas apo-transcobalamin II was not
significantly decreased in hypothyroid patients. Vitamin B12 was not
correlated to transcobalamins. We concluded that the increased vitamin
B12 observed in hypothyroid state could not be explained by changes in
transcobalamins.
Lien et al. (1) have compared the results
at 2-week intervals during two phases. We compared the results
between two states, hypo- and hyperthyroidism, in a larger cohort of
patients. The increase in homocysteine concentrations during
hypothyroidism may be explained by changes in folate status and also by
modifications in enzymes involved in homocysteine metabolism,
distribution or clearance (1, 6), and/or by concurrent
changes in renal function (1). Changes in activities of
5,10-methylenetetrahydrofolate reductase and methionine synthase have
been reported during both hyper- and hypothyroid states in an animal
model (7). Data about normalization of
hyperhomocysteinemia with levothyroxine are conflicting. Normalization
was obtained after 39 months in a study of 14 patients
(8), but failed after 2 months in a cohort of 14 patients
(9).
In conclusion, homocysteine was increased in 22% of our patients
in the hypothyroidism stage. This mild hyperhomocysteinemia was rather
explained by a modification of folates status, with a mild decrease of
blood concentration and a negative correlation between folates and
homocysteinemia, than by a modification of vitamin B12 status and
transport.
References
-
Lien EA, Nedrebo BG, Varhaug JE, Nygard O, Aakvaag A,
Ueland PM. 2000 Plasma total homocysteine levels during short-term
iatrogenic hypothyroidism. J Clin Endocrinol Metab. 85:10491053.[Abstract/Free Full Text]
-
Barbé F, Klein M, Chango A, Weryha G, Nicolas
JP, Leclère J. 1999 Hypothyroidism increases plasma
homocysteine concentrations. J Endocrinol Invest. 22:28.[Medline]
-
Ubbink JB, Vermaak WJH, Bissbort S. 1991 Rapid
high-performance liquid chromatographic assay for total homocysteine
levels in human serum. J Chromatogr. 565:441446.[Medline]
-
Namour F, Olivier JL, Abdelmouttaleb I, et al.
Transcobalamin codon 259 polymorphism in HT29 and Caco-2 cells and in
Caucasians: relation to transcobalamin and homocysteine concentration
in blood. Blood. In press.
-
Nicolas JP, Chango A. 1997 Dérégulation
du métabolisme de lhomocystéine et conséquences
pour le système vasculaire. Bull Acad Natle Méd. 181:313331.
-
Nedrebo BG, Ericsson UB, Nygard O, et al. 1998 Plasma total homocysteine levels in hyperthyroid and hypothyroid
patients. Metabolism. 47:8993.[Medline]
-
Nair CPP, Viswanathan G, Noronha J. 1994 Folate-mediated incorporation of ring-2-carbon of histidine into
nucleic acids: influence of thyroid hormone. Metabolism. 43:15751578.[Medline]
-
Hussein WI, Green R, Jacobsen DW, Faiman C. 1999 Normalization of hyperhomocysteinemia with L-thyroxine in
hypothyroidism. Ann Intern Med. 131:348351.[Abstract/Free Full Text]
-
Catargi B, Parrot-Roulaud F, Cochet C, Ducassou D, Roger
P, Tabarin A. 1999 Homocysteine, hypothyroidism, and effects of
thyroid hormone replacement. Thyroid. 9:11631166.[Medline]